Barclays launches ABIVAX Société (ABVX) with an overweight rating

Barclays launches ABIVAX Société (ABVX) with an overweight rating

​ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the High growth stocks to invest in now. On October 13, Barclays’ Etzer Darout initiated ABIVAX Société Anonyme (NASDAQ:ABVX) with an Overweight rating and a $142 price target. Analysts noted that they began coverage of eight companies in the inflammation, immunology, oncology and rare disease sectors. He explained…

Read More